Sitrin Capital Management LLC Has $4.73 Million Holdings in Agilent Technologies, Inc. (NYSE:A)

Sitrin Capital Management LLC lifted its holdings in Agilent Technologies, Inc. (NYSE:A) by 0.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 35,189 shares of the medical research company’s stock after purchasing an additional 170 shares during the quarter. Agilent Technologies accounts for approximately 2.4% of Sitrin Capital Management LLC’s investment portfolio, making the stock its 22nd biggest holding. Sitrin Capital Management LLC’s holdings in Agilent Technologies were worth $4,727,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. IFP Advisors Inc increased its position in Agilent Technologies by 17.7% during the fourth quarter. IFP Advisors Inc now owns 458 shares of the medical research company’s stock worth $62,000 after buying an additional 69 shares during the last quarter. Brown Brothers Harriman & Co. boosted its stake in shares of Agilent Technologies by 13.5% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 646 shares of the medical research company’s stock worth $96,000 after acquiring an additional 77 shares during the period. Rothschild Investment LLC increased its holdings in shares of Agilent Technologies by 19.2% during the 4th quarter. Rothschild Investment LLC now owns 491 shares of the medical research company’s stock worth $66,000 after acquiring an additional 79 shares during the last quarter. Rovin Capital UT ADV raised its stake in Agilent Technologies by 1.6% in the 3rd quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company’s stock valued at $750,000 after acquiring an additional 81 shares during the period. Finally, Integrated Advisors Network LLC lifted its holdings in Agilent Technologies by 2.5% during the 3rd quarter. Integrated Advisors Network LLC now owns 3,582 shares of the medical research company’s stock valued at $532,000 after purchasing an additional 86 shares during the last quarter.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the sale, the chief executive officer now directly owns 39,652 shares in the company, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Wall Street Analyst Weigh In

A number of brokerages recently commented on A. JPMorgan Chase & Co. decreased their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 26th. Barclays raised Agilent Technologies from an “underweight” rating to an “equal weight” rating and upped their target price for the company from $135.00 to $145.00 in a research report on Monday, February 10th. Sanford C. Bernstein dropped their price target on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a report on Tuesday, November 26th. Bank of America decreased their price objective on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a report on Friday, December 13th. Finally, Wells Fargo & Company dropped their target price on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a report on Monday, December 9th. Seven analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $144.38.

Agilent Technologies Price Performance

A stock opened at $134.05 on Wednesday. The company has a market capitalization of $38.24 billion, a P/E ratio of 30.33, a PEG ratio of 3.66 and a beta of 1.07. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.58 and a current ratio of 2.09. Agilent Technologies, Inc. has a 52-week low of $124.16 and a 52-week high of $155.35. The company has a fifty day moving average price of $140.87 and a 200-day moving average price of $139.31.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.05. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The firm had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same quarter last year, the business earned $1.38 EPS. The company’s revenue was up .8% compared to the same quarter last year. As a group, equities analysts expect that Agilent Technologies, Inc. will post 5.56 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.74%. Agilent Technologies’s payout ratio is currently 22.40%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.